Data as of 4:03pm ET
| +0.10 / +2.24%|
The 4 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 6.05, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +32.39% increase from the last price of 4.57.
The current consensus among 4 polled investment analysts is to Buy stock in China Cord Blood Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.